PubMed:10945637 / 427-672 JSONTXT

{"project":"PubMed_ArguminSci","denotations":[{"id":"T3","span":{"begin":0,"end":245},"obj":"DRI_Challenge"}],"text":"To determine whether FGFs are overexpressed in human prostate cancers, we analyzed 26 prostate cancer RNAs by reverse transcription-PCR for expression of FGF3, FGF4, and FGF6, which cannot be detected in normal prostate tissue by this technique."}

{"project":"PubmedHPO","denotations":[{"id":"T3","span":{"begin":53,"end":69},"obj":"HP_0012125"},{"id":"T4","span":{"begin":62,"end":69},"obj":"HP_0002664"},{"id":"T5","span":{"begin":86,"end":101},"obj":"HP_0012125"},{"id":"T6","span":{"begin":95,"end":101},"obj":"HP_0002664"}],"text":"To determine whether FGFs are overexpressed in human prostate cancers, we analyzed 26 prostate cancer RNAs by reverse transcription-PCR for expression of FGF3, FGF4, and FGF6, which cannot be detected in normal prostate tissue by this technique."}